Pharmacy benefit managers would be prohibited from accepting compensation based on the price or utilization of a drug as a condition of entering into a contract with a Medicare Part D plan, under a bill announced by the Senate Finance Committee on 14 June.
Separating compensation from price and utilization aims to address concerns that current practices encourage higher list prices and disadvantage patients whose cost sharing is based on the list price rather than the net
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?